EXPD vs IMA · P/E 26, rev $10.60B vs rev $9.2M
Expeditors International of Washington, Inc. (EXPD) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. IMA currently screens at market cap $64.7M.
Not investment advice. Open the EXPD and IMA stock pages for the full models.
Not investment advice.